TY - JOUR
T1 - Treatment burden and perceptions of glucose-lowering therapy among people living with diabetes
AU - González-Saldivar, Gerardo
AU - Millan-Alanis, Juan Manuel
AU - González-González, José Gerardo
AU - Sánchez-Gómez, Raymundo A.
AU - Obeso-Fernández, Javier
AU - McCoy, Rozalina G.
AU - Maraka, Spyridoula
AU - Brito, Juan P.
AU - Ospina, Naykky Singh
AU - Oyervides-Fuentes, Stephie
AU - Rodríguez-Gutiérrez, René
N1 - Funding Information:
None. Dr. McCoy advises Emmi® on the development of diabetes-related education materials and has received support from NIDDK , PCORI , and AARP ® . This effort was funded in part by the National Institute of Health ( NIH ) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant number K23DK114497 (RM). NSO was supported by the National Cancer Institute of the National Institutes of Health under Award Number K08CA248972 . SM was supported by the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000, and by the United States Department of Veterans Affairs Health Services Research & Development Service of the VA Office of Research and Development, under Merit review award number 1I21HX003268-01A1 . Study contents are the sole responsibility of the authors and do not necessarily represent the official views of NIH, the Department of Veterans Affairs, or the United States Government.
Funding Information:
None. None. Dr. McCoy advises Emmi® on the development of diabetes-related education materials and has received support from NIDDK, PCORI, and AARP®. This effort was funded in part by the National Institute of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant number K23DK114497 (RM). NSO was supported by the National Cancer Institute of the National Institutes of Health under Award Number K08CA248972. SM was supported by the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000, and by the United States Department of Veterans Affairs Health Services Research & Development Service of the VA Office of Research and Development, under Merit review award number 1I21HX003268-01A1. Study contents are the sole responsibility of the authors and do not necessarily represent the official views of NIH, the Department of Veterans Affairs, or the United States Government.
Publisher Copyright:
© 2022 Primary Care Diabetes Europe
PY - 2022/8
Y1 - 2022/8
N2 - Aims: Address treatment burden and general perceptions of pharmacological treatment in patients with diabetes. Methods: We surveyed adult patients with diabetes cared for in a tertiary academic medical center about: i) knowledge about the impact of glucose-lowering medication use on diabetes control and complications, ii) common beliefs about natural medicine and insulin use, iii) attitudes towards glucose-lowering medications, iv) burden of treatment, v) general knowledge of diabetes pharmacological treatment, and vi) perceptions of shared decision-making. Results: Two hundred-four participants completed the survey. While most (90%) agreed that adherence to medication would control diabetes and improve quality of life, 30–40% were not certain that it would translate to fewer disease complications. About one of three thought medications could be harmful (29.4%). Over 50% agreed or was unsure that natural remedies were as good/better than prescribed medications. About 30% acknowledged difficulties taking their diabetes medications and monitoring blood glucose, and over 50% were concerned about treatment costs. Nearly 30% denied receiving a detailed explanation from their clinician regarding their disease and is treatment. Conclusions: Our results highlight the importance of patient education regarding pharmacological treatment for diabetes, and eliciting sources of distress and treatment burden among patients with diabetes.
AB - Aims: Address treatment burden and general perceptions of pharmacological treatment in patients with diabetes. Methods: We surveyed adult patients with diabetes cared for in a tertiary academic medical center about: i) knowledge about the impact of glucose-lowering medication use on diabetes control and complications, ii) common beliefs about natural medicine and insulin use, iii) attitudes towards glucose-lowering medications, iv) burden of treatment, v) general knowledge of diabetes pharmacological treatment, and vi) perceptions of shared decision-making. Results: Two hundred-four participants completed the survey. While most (90%) agreed that adherence to medication would control diabetes and improve quality of life, 30–40% were not certain that it would translate to fewer disease complications. About one of three thought medications could be harmful (29.4%). Over 50% agreed or was unsure that natural remedies were as good/better than prescribed medications. About 30% acknowledged difficulties taking their diabetes medications and monitoring blood glucose, and over 50% were concerned about treatment costs. Nearly 30% denied receiving a detailed explanation from their clinician regarding their disease and is treatment. Conclusions: Our results highlight the importance of patient education regarding pharmacological treatment for diabetes, and eliciting sources of distress and treatment burden among patients with diabetes.
KW - Burden of treatment
KW - Diabetes
KW - Financial burden
KW - Medication adherence
KW - Patient reported outcomes
KW - Shared decision-making
UR - http://www.scopus.com/inward/record.url?scp=85129031833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129031833&partnerID=8YFLogxK
U2 - 10.1016/j.pcd.2022.04.002
DO - 10.1016/j.pcd.2022.04.002
M3 - Article
C2 - 35466069
AN - SCOPUS:85129031833
SN - 1751-9918
VL - 16
SP - 568
EP - 573
JO - Primary Care Diabetes
JF - Primary Care Diabetes
IS - 4
ER -